Je suis en accord avec toi growacet, it's nice when people take interest in RVX news. Nice!
Resverlogix recently completed the Phase 3 clinical study BETonMACE (NCT02586155), testing apabetalone on high-risk cardiovascular disease patients with type 2 diabetes mellitus and low levels of high-density lipoprotein.
But that statement is false.
Cant wait for completion. Tick tock.